Full name
PHARMA NOVA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0 | -0,3 | -828,3 |
EBITDA | 0 | -0 | -0,3 | -829,9 |
Short time liabilities | 0 | 0 | 0,1 | -∞ |
Equity capital | 0,1 | -0 | -0,3 | -3196,1 |
Operating profit (EBIT) | 0 | -0 | -0,3 | -829,9 |
Assets | 0,1 | 0 | 0,7 | 3609 |
Net profit (loss) | 0 | -0 | -0,3 | -828,3 |
Cash | 0 | 0 | 0 | 144 |
Net income from sale | 0 | 0 | 0,2 | -∞ |
Liabilities and provisions for liabilities | 0 | 0 | 1 | 3465,7 |
Working assets | 0 | 0 | 0,7 | 3609 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0 | 344,3 | 97 | -247,3 |
Equity capital to total assets | 100 | -53,2 | -47,3 | 5,9 |
Gross profit margin | -189,1 | |||
EBITDA Margin | -189,4 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 225 | 225 |
Current financial liquidity indicator | 6.704205513000488 | |||
Net dept to EBITDA | 0.3292372524738312 | -2.7974343299865723 | -3,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane